Evidence map›Paper›PMID 41752138›Full record

ArticleInternational journal of molecular sciences2026

Improvement of Cardiac Function by Polyclonal Antibodies Against Ca

Naranjan S Dhalla, Vijayan Elimban, Petr Ostadal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Naranjan S DhallaInstitute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, and Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
Vijayan ElimbanInstitute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, and Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
Petr OstadalDepartment of Cardiology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, 15000 Prague, Czech Republic.ORCID 0000-0001-9550-222X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delayed reperfusion of an ischemic heart is known to impair the recovery of cardiac function, and the occurrence of intracellular Ca

Indexed as

AntibodiesCa(2+) Mg(2+)-ATPaseHeartMyocardial Reperfusion InjuryAnimalsCalciumMaleMyocardiumRatsSarcolemmaAntibodiesCa(2+) Mg(2+)-ATPaseCalciumATP-induced increase in [Ca2+]iCa2+/Mg2+ ecto-ATPase antibodiescardiac functionintracellular Ca2+ overloadischemia-reperfusion injurymyocardial Ca2+ contentsarcolemmal Ca2+/Mg2+ ecto-ATPase

Identifiers

PMID41752138
PMCPMC12941162

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.